A

Arrowhead Pharmaceuticals
D

ARWR

19.900
USD
-1.04
(-4.97%)
مغلق
حجم التداول
43,981
الربح لكل سهم
-4
العائد الربحي
-
P/E
-4
حجم السوق
2,509,352,409
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    -0.480
    (-0.19%)
    250.450 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    N
    NTLA
    -0.075
    (-0.61%)
    12.180 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    S
    SLDB
    -0.22000
    (-3.67%)
    5.77500 USD
    V
    VYGR
    -0.04000
    (-0.94%)
    4.22500 USD
    المزيد
الأخبار
المقالات

العنوان: Arrowhead Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.